Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Greater insulin resistance tied to increased BMD, but not fracture risk

13 Jul 2019

An association exists between greater insulin resistance (IR) and higher bone mineral density (BMD) in nondiabetic older adults, but evidence for an increased fracture risk with greater IR is inconsistent, a recent study has found.

The homeostatic model assessment (HOMA) of IR quartiles had cutoff values of 1.05, 1.54 and 2.33. The fourth HOMA-IR quartile showed 0.104-g/cm2 higher total hip BMD than the first quartile (p<0.001). Adjustment made for body mass index (BMI) attenuated this difference (adjusted mean difference, 0.007 g/cm2; p=0.371).

Unadjusted models showed a lower fracture risk in participants with higher HOMA-IR (third quartile: hazard ratio [HR], 0.86, 95 percent CI, 0.73–1.01; fourth quartile: HR, 0.65, 0.47–0.89, as compared with the first quartile).

However, fracture risk became significantly greater in the third quartile (HR, 1.19, 1.00–1.41) and slightly higher in the fourth quartile (HR, 1.12, 0.87–1.46) compared with the first quartile when adjustments were made for BMD and BMI.

“In contrast to the relationship between type 2 diabetes (T2D) and fracture risk, we did not find consistent evidence that greater IR is associated with increased fracture risk after adjustment for BMI and BMD,” the investigators said.

This study examined the relationship among HOMA-IR, BMD and incident nonspine fractures in 2,398 community-dwelling, nondiabetic older adults (mean age, 74±3 years; 53 percent women; 38 percent black) in the Health, Aging and Body Composition Prospective Cohort Study (median follow-up, 12 years).

“Adults with T2D have higher fracture risk compared with nondiabetics, despite having higher BMD,” the investigators said. “IR has been associated with increased BMD.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.